| Status | Study |
| Completed |
Study Name: Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis Condition: Facial Angiofibroma Date: 2017-04-26 Interventions: Drug: Rapamycin |
| Not yet recruiting |
Study Name: Topical Everolimus in Patients With Tuberous Sclerosis Complex Condition: Facial Angiofibromas Date: 2016-08-04 Interventions: Drug: Everolimus Everolimus to |
| Not yet recruiting |
Study Name: Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex Condition: Tuberous Sclerosis Angiofibroma Date: 2015-12-16 Interventions: Drug: NPC-12G gel NPC-12G gel is administered topically twice a day for 52 weeks or longer |
| Completed |
Study Name: Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) Condition: Tuberous Sclerosis Angiofibroma Date: 2015-12-15 Interventions: Drug: NPC-12G gel NPC-12G gel |
| Completed |
Study Name: Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream Condition: Facial Angiofibroma Date: 2013-04-12 Interventions: Drug: Rapamune Small amount of 0.1% rapamune ointment applied topically to affected facial areas twice d |
| Completed |
Study Name: Topical Rapamycin to Erase Angiofibromas in TSC Condition: Angiofibromas Tuberous Sclerosis Date: 2012-02-01 Interventions: Drug: Placebo Study cream is a |
| Active, not recruiting |
Study Name: Stereotactic Body Radiotherapy for Head and Neck Tumors Condition: Squamous Cell Carcinoma of the Head and Neck Nasopharyngeal Carcinoma Date: 2011-04-27 Interventions: Radiation: stereotactic body radiotherapy |
| Completed |
Study Name: Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) Condition: Tuberous Sclerosis Neurofibromatoses Date: 2009-12-10 Interventions: Drug: Skincerity Study subject |